Analysis of whole-exome and RNA-seq data from matched primary and metastatic tumor samples in a cohort of high-grade serous ovarian cancer patients reveals distinct genomic and transcriptomic alterations associated with survival outcomes.
- Emilee N. Kotnik
- Mary M. Mullen
- Katherine C. Fuh